On Nov 14, major Wall Street analysts update their ratings for $Biohaven (BHVN.US)$, with price targets ranging from $59 to $76.
BofA Securities analyst Jason Gerberry maintains with a buy rating.
TD Cowen analyst Tyler Van Buren maintains with a buy rating, and maintains the target price at $75.
Piper Sandler analyst Christopher Raymond maintains with a buy rating, and maintains the target price at $76.
H.C. Wainwright analyst Douglas Tsao maintains with a buy rating, and maintains the target price at $59.
Furthermore, according to the comprehensive report, the opinions of $Biohaven (BHVN.US)$'s main analysts recently are as follows:
The revision in the anticipated price reflects the company's Q3 operating expenses surpassing expectations and the recent capital increase. Nevertheless, the company is still expected to achieve significant value-creating milestones by the year's end.
The firm anticipates that the Phase III data for T-alfa in SMA will present a favorable risk/reward profile. Additionally, towards the year's end, they are looking forward to updates on the SAD/MAD/subQ IgG degrader data for BHV-1300, as well as the IND submissions for three more candidates from the MoDE degrader platform.
Here are the latest investment ratings and price targets for $Biohaven (BHVN.US)$ from 4 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
